Status:
COMPLETED
Biomarkers of Bone Resorption in Metastatic Prostate Cancer
Lead Sponsor:
University of Aberdeen
Conditions:
Metastatic Prostate Cancer
Eligibility:
MALE
40-80 years
Brief Summary
Biomarkers of bone resorption will be measured in the blood of patients with bone metastases from prostate cancer during the course of their illness. Changes in these biomarkers will be correlated wit...
Eligibility Criteria
Inclusion
- prostate cancer with bone metastases
- hormone sensitive
Exclusion
- inadequate renal function
- ongoing dental problems
- previous bisphosphonate therapy
Key Trial Info
Start Date :
September 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2014
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT01233557
Start Date
September 1 2010
End Date
August 1 2014
Last Update
November 5 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aberdeen Royal Infirmary
Aberdeen, United Kingdom, AB25 2ZN